DuraMed Study |
||||
|
Fertility Centers of Illinois, SC, along with several other large infertility practices in the country, is participating in a Phase III Clinical Trial of an investigational drug for progesterone supplementation. For subjects who qualify and are accepted into the study, Fertility Centers of Illinois, SC can provide an IVF cycle for to up to 80 subjects at no cost. Participants will be responsible for the cost of all IVF medications, as well as embryo freezing and storage.
Subjects will be assigned to one of our two IVF centers. Subjects will initially be seen at our River North Chicago office, subsequent IVF monitoring can be done at either our River North or Highland Park IVF centers. After successful IVF stimulation and egg retrieval, subjects will be assigned to one of two progesterone treatment groups. Subjects will be either assigned to a group that will take the FDA approved progesterone drug or to a group that will take the investigational drug. As with all drug studies there are strict criteria established by the study sponsor for both inclusion end exclusion into the study.
Criteria for inclusion include:
Criteria for exclusion include:
To read the press release about this study, please click here.
If you feel that you qualify for this study based on meeting the criteria above, please click here to fill out the Study Questionnaire.
|
||||